基本信息
views: 0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Grants
A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Adults Diagnosed With Epilepsy awarded by Xenon Pharmaceuticals Inc. 2023 - 2028
The overlap of speech production and verbal working memory awarded by National Institutes of Health 2023 - 2028
Promoting Effective Self-Management of Chronic Pain with mHealth Neurofeedback awarded by National Institutes of Health 2022 - 2027
A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures awarded by Xenon Pharmaceuticals Inc. 2023 - 2025
MARN - Protocol 1042-SE-3004_Imaging awarded by Marinus Pharmaceuticals, Inc. 2023 - 2025
Epilepsy in Uganda: Clinical characterization and co-morbidities, their relation to stigma among adolescents and impact of a community-based intervention awarded by Makerere University 2021 - 2024
Epilepticus_EEG Coordinating Ctr. awarded by Marinus Pharmaceuticals, Inc. 2020 - 2023
Phase I Single Ascending Dose and Multiple Ascending Dose Study of 2R,6R-Hydroxynorketamine awarded by National Institutes of Health 2018 - 2023
Neuromodulatory Treatments for Pain Management in Complex TBI using Mobile Technology awarded by Department of Defense 2017 - 2022
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Exploring the Efficacy, Safety and Tolerability of Natalizumab (BG00002) as Adjunctive Therapy in Adult Subjects With Drug-Resistant Focal Epilepsy awarded by Biogen, Inc. 2018 - 2021
A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Adults Diagnosed With Epilepsy awarded by Xenon Pharmaceuticals Inc. 2023 - 2028
The overlap of speech production and verbal working memory awarded by National Institutes of Health 2023 - 2028
Promoting Effective Self-Management of Chronic Pain with mHealth Neurofeedback awarded by National Institutes of Health 2022 - 2027
A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures awarded by Xenon Pharmaceuticals Inc. 2023 - 2025
MARN - Protocol 1042-SE-3004_Imaging awarded by Marinus Pharmaceuticals, Inc. 2023 - 2025
Epilepsy in Uganda: Clinical characterization and co-morbidities, their relation to stigma among adolescents and impact of a community-based intervention awarded by Makerere University 2021 - 2024
Epilepticus_EEG Coordinating Ctr. awarded by Marinus Pharmaceuticals, Inc. 2020 - 2023
Phase I Single Ascending Dose and Multiple Ascending Dose Study of 2R,6R-Hydroxynorketamine awarded by National Institutes of Health 2018 - 2023
Neuromodulatory Treatments for Pain Management in Complex TBI using Mobile Technology awarded by Department of Defense 2017 - 2022
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Exploring the Efficacy, Safety and Tolerability of Natalizumab (BG00002) as Adjunctive Therapy in Adult Subjects With Drug-Resistant Focal Epilepsy awarded by Biogen, Inc. 2018 - 2021
Research Interests
Papers共 144 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
James W Mitchell, Frieda Sossi, Isabel Miller, Paula Blancarte Jaber,Zofia Das-Gupta,Luz Sousa Fialho,Action Amos,Joan K Austin, Scott Badzik,Gus Baker,Bruria Ben Zeev,Jeffrey Bolton,
Epilepsiano. 7 (2024): 1938-1961
Clinical Neurophysiology (2024): 2-8
James W Mitchell, Frieda Sossi, Isabel Miller, Paula Blancarte Jaber,Zofia Das-Gupta,Luz Sousa Fialho,Action Amos,Joan K Austin, Scott Badzik,Gus Baker,Bruria Ben Zeev,Jeffrey Bolton,
Epilepsiano. 7 (2024): 1916-1937
SLEEP MEDICINE (2024): 328-337
Jaime R López, Linda Kelly, Judy Ahn-Ewing, Ron Emerson, Carrie Ford,Clare Gale, Jeffery H Gertsch,Aatif Husain,John Kincaid,Meledy Kise, Adam Kornegay,Joseph J Moreira,
Journal of clinical neurophysiology : official publication of the American Electroencephalographic Societyno. 2 (2024): 188-189
Clinical pharmacology in drug developmentno. 3 (2024): 248-258
World Neurosurgery (2024): 170-176
JAMA Neurology (2023): 805-812
Nature and science of sleep (2023): 593-606
Load More
Author Statistics
#Papers: 145
#Citation: 3925
H-Index: 34
G-Index: 60
Sociability: 6
Diversity: 3
Activity: 13
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn